BIRC5 and diffuse large B-cell lymphoma: Another survivin inhibitor SM1044 is a new water-soluble artemisinin derivative of antimalarial drug, inducing the degradation of survivin through acetylation-dependent interaction with LC3-II to promote the apoptosis of the DLBCL cell line.